Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia
Stopped This study was terminated January 11, 2011 due to low enrollment. This study is not being terminated because of safety or efficacy concerns.
Conditions
- Community-Acquired Pneumonia
Interventions
- DRUG: Azithromycin SR
- DRUG: Amoxiclav
Sponsor
Pfizer